SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-022030
Filing Date
2024-05-31
Accepted
2024-05-30 18:01:22
Documents
73
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1174717
2 ex31-1.htm EX-31.1 12674
3 ex31-2.htm EX-31.2 12956
4 ex32-1.htm EX-32.1 6470
5 ex32-2.htm EX-32.2 7187
  Complete submission text file 0001493152-24-022030.txt   6659506

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vtro-20240430.xsd EX-101.SCH 57336
7 XBRL CALCULATION FILE vtro-20240430_cal.xml EX-101.CAL 76699
8 XBRL DEFINITION FILE vtro-20240430_def.xml EX-101.DEF 216479
9 XBRL LABEL FILE vtro-20240430_lab.xml EX-101.LAB 441233
10 XBRL PRESENTATION FILE vtro-20240430_pre.xml EX-101.PRE 328422
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1058975
Mailing Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209
Business Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209 8558487627
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-41766 | Film No.: 241006960
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)